EUA
Alpha Genomix TaqPath SARS-CoV-2 Combo Assay
FDA Emergency Use Authorization · Alpha Genomix Laboratories · Jan 28, 2021
Key facts
| Product | Alpha Genomix TaqPath SARS-CoV-2 Combo Assay |
|---|---|
| Company | Alpha Genomix Laboratories |
| Product type | Real-time RT-PCR, Multiple Targets |
| Date | Jan 28, 2021 |
| FDA page | fda.gov |
At a glance
- 1–9 Authorization documents
- 1–9 EUAs for this company
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Emergency Use Authorizations
Emergency Use Authorizations allow the FDA to permit unapproved medical products, or unapproved uses of approved products, during a declared public health emergency.
Source: U.S. Food and Drug Administration (FDA), Emergency Use Authorizations · Source date: